Low-Dose, Extended-Release Morphine for Chronic Breathlessness in COPD
Results of a clinical trial do not support the use of daily low-dose, extended-release morphine to relieve severe chronic breathlessness in people with COPD. The
Results of a clinical trial do not support the use of daily low-dose, extended-release morphine to relieve severe chronic breathlessness in people with COPD. The
In a real-world cohort study from the U.K., patients had fewer COPD exacerbations when diabetes was treated with GLP-1 agonists or SGLT-2 inhibitors than with